Production (Stage)
Bio-Path Holdings, Inc.
BPTH
$0.18
-$0.01-5.26%
OTC PK
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 56.44% | -38.65% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 23.47% | -0.34% | |||
Operating Income | -23.47% | 0.34% | |||
Income Before Tax | -3.60% | -30.17% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -3.60% | -30.17% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -3.60% | -30.17% | |||
EBIT | -23.47% | 0.34% | |||
EBITDA | -24.29% | 0.84% | |||
EPS Basic | 36.69% | 8.99% | |||
Normalized Basic EPS | 36.71% | 8.97% | |||
EPS Diluted | 36.69% | 8.99% | |||
Normalized Diluted EPS | 36.71% | 8.97% | |||
Average Basic Shares Outstanding | 63.66% | 43.02% | |||
Average Diluted Shares Outstanding | 63.66% | 43.02% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |